picotamide has been researched along with Complications of Diabetes Mellitus in 2 studies
picotamide: has anticoagulant & fibrinolytic properties; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Picotamide is an antiplatelet drug which inhibits thromboxane A2 (TxA2) synthase and antagonizes TxA2 receptors." | 2.68 | Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study. ( Longoni, A; Maderna, M; Milani, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cocozza, M | 1 |
| Picano, T | 1 |
| Oliviero, U | 1 |
| Russo, N | 1 |
| Coto, V | 1 |
| Milani, M | 2 |
| Longoni, A | 1 |
| Maderna, M | 1 |
2 trials available for picotamide and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Effects of picotamide, an antithromboxane agent, on carotid atherosclerotic evolution. A two-year, double-blind, placebo-controlled study in diabetic patients.
Topics: Administration, Oral; Aged; Carotid Stenosis; Diabetes Complications; Double-Blind Method; Female; H | 1995 |
Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
Topics: Arterial Occlusive Diseases; Diabetes Complications; Double-Blind Method; Hemodynamics; Humans; Inte | 1996 |